+91-9836913164 (India),  +1-917-730-4660 (U.S.)
Humanized Mouse and Rat Model Market is expected to grow at CAGR 9.13%till 2025 - Global Industry Size, Share, Growth, Market Analysis and Forecast
Published : August 2018

Global Humanized Mouse and Rat Model market in terms of revenue is expected to reach $172.83million by 2025 at a CAGR of 9.13% from 2018 to 2025 as per new market research report titled Global Humanized Mouse and Rat Model Market (Bymodelstype- cell-based models, and genetic models. By application- hematopoiesis, oncology, toxicology, autoimmunity, infection diseases, and others. By end-user- contract research organization, the pharmaceutical industry, and others) - global industry analysis, size, share, growth, trends, and forecast, 2017 – 2025, by Sheer Analytics & Insights Pvt. Ltd.



Global Humanized Mouse and Rat Model Market CAGR Forecast 2018 - 2025 Sheer Analytics and Insights


In the laboratories for modeling, the human biology and diseases humanized mouse and rat models are used. They are also known by Knocking model and are used as a replacement of mouse gene by human gene or genomic sequence. It is termed as knocking as this technology consist of the deletion of a gene from the mouse genome and then it is replaced by human ortholog or gene.


In rising number of application areas for humanized mouse & rat model which includes infection diseases, oncology among others is the prime factor for the growth of this market. Investment by the key players in ensuring better healthcare facilities is one of the most influencing factors for making the market more demanding during the estimated period. Increasing occurrence of cancer diseases, surge in the production of monoclonal antibodies along with the stem cell exploration are some other factors contributing towards the growth of the humanized mouse & rat model market.


From the past few years, the global humanized mouse and rat market is dominated by North-America. The major reasons for which the demand for humanized mouse and rat model is increasing are the growth in monoclonal antibody production, preclinical activities by CROs and pharmaceutical R&D. The market is growing also owing to the continuous and responsible use of animals which is ensured by the animal care organizations.


Furthermore, it is estimated that the growth of the humanized mouse and rat model market will increase in Asia-Pacific owing to the international alliances for research and development activities conducted in China. In this alliance, China has taken initiatives for reducing the approval time for drugs, mandatory animal testing for every type of pharmaceutical drug along with cosmetics. The demand for this market is also increasing in India owing to the growth of the biomedical industry and the development of bio-clusters.


While emphasizing on the importance of mice in cancer research, Charles Hewett, Jackson Lab's former executive vice president and chief operating officer mentioned,"Mice are small, relatively speaking, they're inexpensive to house, they're inexpensive to feed and, best of all perhaps, they breed incredibly quickly. Jax pioneered the use of mice in genetic research and we believe very strongly in the importance of this work — work to solve the critical problems of human health and to identify and test better treatments."


In the recent market research report that was published by Sheer Analytics & Insights, the global humanized mouse and rat model market has been segmented based on the model’s type, application, and end-user. Based on the model's type, the market has been analyzed as cell-based models and genetic models. The cell-based models further sub-segmented into BLT model, CD34, and PBMC. The major end-user of global humanized mouse and rat model market includes contract research organization, the pharmaceutical industry, and others. Moving forward, the market is further segmented by an application such as hematopoiesis, oncology, toxicology, autoimmunity, infection diseases, and others. Geographically, global humanized mouse and rat model market segmented into North America, Middle East & Africa, Asia-Pacific, and Latin America.


Some of the major players of humanized mouse and rat model market includeAxenis S.A.S., Crown Bioscience, Inc., Champions Oncology, Charles River Laboratories, GenOway S.A., Harbour Antibodies BV, Ingenious Targeting Laboratory, and Taconic Biotechnology Co.


Global Humanized Mouse & Rat Model Market: By Models Type

  • Cell-based models
  • BLT model
  • CD34
  • PBMC
  • Genetic models

Global Humanized Mouse & Rat Model Market: By Application

  • Hematopoiesis
  • Oncology
  • Toxicology
  • Autoimmunity
  • Infection diseases
  • Others

Global Humanized Mouse & Rat Model Market: By End-User

  • Contract research organization
  • Pharmaceutical industry
  • Others

Global Humanized Mouse & Rat Model Market: By Geography

North America

  • U.S.
  • Canada
  • Mexico


  • U.K.
  • France
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • India
  • China
  • Japan
  • Rest of Asia Pacific

Middle East and Africa

  • South Africa
  • Rest of Middle East and Africa

Latin America

  • Brazil
  • Rest of Latin America



About Sheer Analytics and Insights Private Limited

Sheer Analytics and Insights Pvt. Ltd. is among the leading market research organizations providing the best B2B researches on various niches. Currently servicing 2000+ clients worldwide, our analysts and marketing team are continually tracking global markets having high growth prospect.

Contact info

Contact Number: +913346009199

Email Address: sales@sheeranalyticsandinsights.com

Copyright © 2018 Sheer Analytics and Insights

All Rights Reserved. This document contains highly confidential information and is the sole property of the Company. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of the company.